We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Home » New England Journal of Medicine Publishes FAME II Trial Results Revealing Better Patient Outcomes With FFR-Guided Cardiac Stenting
New England Journal of Medicine Publishes FAME II Trial Results Revealing Better Patient Outcomes With FFR-Guided Cardiac Stenting
August 28, 2012
St. Jude Medical, Inc., a global medical device company, today announced results of the FAME II Trial demonstrating that patients with FFR-guided stenting plus the best available medical therapy had superior outcomes to those treated with medical therapy alone. heraldonline.com
